ProCE Banner Activity

Long-Acting ART: Cabotegravir Plus Rilpivirine

Podcast Episodes

Listen to Ian Frank, MD, discuss long-acting HIV treatment with cabotegravir plus rilpivirine for treatment-experienced PWH, including efficacy data, initiation strategies, virologic failure data, and safety information.

Released: May 10, 2023

Share

Faculty

Ian Frank

Ian Frank, MD

Professor Of Medicine
Associate Chief, Division of Infectious Diseases
University of Pennsylvania
Philadelphia, Pennsylvania

 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grant from ViiV Healthcare.

ViiV Healthcare

Faculty Disclosure

Primary Author

Ian Frank, MD

Professor Of Medicine
Associate Chief, Division of Infectious Diseases
University of Pennsylvania
Philadelphia, Pennsylvania

 

Ian Frank, MD: consultant/advisor/speaker: Gilead, Merck, Moderna, ViiV; researcher: Janssen, Moderna, Pfizer, Sanofi.